Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Cancer drug shows promise in treating metabolic syndrome

Cancer drug shows promise in treating metabolic syndrome

Deterministic mechanoporation of cells en masse to cure cancer

Deterministic mechanoporation of cells en masse to cure cancer

Leukemia type B cell can transform into a macrophage through epigenetic changes

Leukemia type B cell can transform into a macrophage through epigenetic changes

New AI-driven approach for single blood cell classification

New AI-driven approach for single blood cell classification

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

New textbook on mysterious and deadly cytokine storm syndrome

New textbook on mysterious and deadly cytokine storm syndrome

New blood filtering system could draw disease from the body using magnets

New blood filtering system could draw disease from the body using magnets

Preclinical data on new drug combination to treat neuroblastoma published

Preclinical data on new drug combination to treat neuroblastoma published

New technique to detect common cause for diseases related to thrombotic microangiopathies

New technique to detect common cause for diseases related to thrombotic microangiopathies

New stem cell technology gives new hope for high-risk leukemia patients

New stem cell technology gives new hope for high-risk leukemia patients

Finding ways to stop cancer at its roots

Finding ways to stop cancer at its roots

Fujitsu successfully verifies AI technology to improve efficiency in cancer genomic medicine

Fujitsu successfully verifies AI technology to improve efficiency in cancer genomic medicine

Nanotechnologies can lead to big advances in cancer therapy

Nanotechnologies can lead to big advances in cancer therapy

New stem cell transplant lowers complications for patients with acute blood cancers

New stem cell transplant lowers complications for patients with acute blood cancers

Researchers discover new process of antitumor response of NK cells in myeloma

Researchers discover new process of antitumor response of NK cells in myeloma

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

New guide for genomic diagnosis of myelodysplastic syndromes and chronic myelomonocytic leukemia published

New guide for genomic diagnosis of myelodysplastic syndromes and chronic myelomonocytic leukemia published

Chemotherapy can cause drug-resistant mutations in pediatric ALL patients who relapse

Chemotherapy can cause drug-resistant mutations in pediatric ALL patients who relapse

Avocados may hold the key to managing obesity and preventing diabetes

Avocados may hold the key to managing obesity and preventing diabetes

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.